RYTM

rhythm-pharma-sees-q4-net-product-revenues-from-global-sales-of-imcivree-to-be-about-$57m

Biotechnology RYTM Uncategorized

Rhythm Pharma sees Q4 net product revenues from global sales of IMCIVREE to be about $57M

Jan 9, 2026

Comments Rhythm Pharmaceuticals (RYTM) on Friday said it expects net product revenues from global sales...

rhythm-advances-lead-asset-into-late-stage-trial-in-prader-willi-syndrome

Biotechnology RYTM Uncategorized

Rhythm advances lead asset into late-stage trial in Prader-Willi syndrome

Dec 11, 2025

On the Move Comments Rhythm Pharma (RYTM) added ~15% on Thursday after the company announced...